Newly diagnosed Crohn’s disease, and hepatocellular and renal cell carcinoma in a bariatric surgery patient—dealing with the complexity of obesity-associated diseases: a case report and review of the literature

Table 1 Overview on the patient’s obesity-associated comorbidities

	Diagnosis	Presurgery status/treatment	Postsurgery status/treatment
Resolved	Crohn’s Disease	Oral corticosteroid (budenoside); diarrhea 3× per day	Asymptomatic (medication stopped)
	GERD	Regular postprandial reflux symptoms; short segment Barrett’s esophagus	Asymptomatic (pantoprazole intake in combination with NSAIDs for arthrosis)
	HCC	pT1b G2	Complete resection; no recurrence during follow-up
	OSA	CPAP	Asymptomatic (CPAP no longer required)
Improved	Arterial hypertension	6 antihypertensives (spironolactone, torasemide, metoprolol, amlodipine, valsartan, hydrochlorothiazide)	2 antihypertensives (spironolactone, metoprolol)
	Type 2 diabetes	HbA1c 5.2%; no medication	HbA1c 4.7%
	Arthrosis	Regular NSAID and opioid intake (tilidine)	On-demand medication with NSAIDs
	Heart failure	NYHA Class III	NYHA Class II
Unchanged/no follow-up	Hyperlipidemia	Statin therapy	Unchanged
Unchanged/no follow-up	Hepatic steatosis	25% of hepatocytes	No follow-up data available

HbA1c glycated hemoglobin, OSA obstructive sleep apnea, CPAP continuous positive airway pressure, GERD gastroesophageal reflux disease, HCC hepatocellular carcinoma, NYHA New York Heart Association Functional Classification, NSAID non-steroidal anti-inflammatory drug

ISSN: 1752-1947